Oncology Day Hospital Department

Oncology Day Hospital Department provides modern antitumor drug therapy for patients with various solid malignant tumors on an outpatient basis. The main objective of the department is to deliver effective and safe treatment while allowing patients to maintain their usual lifestyle without the need for round-the-clock hospitalization.

Main Areas of Activity

The department provides neoadjuvant and adjuvant therapy, as well as treatment for metastatic disease in patients with the following malignancies: breast cancer, kidney cancer, skin melanoma, esophageal cancer, gastric cancer, colorectal cancer, head and neck tumors, ovarian cancer, lung cancer, and bladder cancer.

The department administers modern antitumor drug therapy regimens that do not require round-the-clock hospitalization:

  • chemotherapy
  • targeted therapy
  • immunotherapy
  • hormone therapy
  • Personalized antitumor therapy is selected based on the molecular profile of the tumor (tests are performed in the laboratories of the Loginov Moscow Clinical Scientific Center). Patients are continuously monitored throughout all stages of therapy, including assessment of treatment tolerance and timely management of adverse events.

    Oncology Day Hospital Department provides modern antitumor drug therapy for patients with various solid malignant tumors on an outpatient basis. The main objective of the department is to deliver effective and safe treatment while allowing patients to maintain their usual lifestyle without the need for round-the-clock hospitalization.

    Main Areas of Activity

    The department provides neoadjuvant and adjuvant therapy, as well as treatment for metastatic disease in patients with the following malignancies: breast cancer, kidney cancer, skin melanoma, esophageal cancer, gastric cancer, colorectal cancer, head and neck tumors, ovarian cancer, lung cancer, and bladder cancer.

    The department administers modern antitumor drug therapy regimens that do not require round-the-clock hospitalization:

    • chemotherapy
    • targeted therapy
    • immunotherapy
    • hormone therapy

    Personalized antitumor therapy is selected based on the molecular profile of the tumor (tests are performed in the laboratories of the Loginov Moscow Clinical Scientific Center). Patients are continuously monitored throughout all stages of therapy, including assessment of treatment tolerance and timely management of adverse events.

    Ремонт главного входа в корпус №1 МКНЦ

    Уважаемые пациенты! В период с 1 июня по 26 июля 2024 г. будут проходить ремонтные работы главного входа в первый корпус. Для обеспечения безопасности посетителей и персонала, вход временно закроют для прохода в Центр. На время ремонта, пожалуйста, воспользуйтесь входами в: Отделении лучевых методов лечения; Отделении радиоизотопной диагностики. Для вашего удобства на территории будут работать сотрудники, которые помогут вам найти ближайший действующий вход в первый корпус. Приносим извинения за временные неудобства и надеемся на ваше понимание. Мы делаем всё, чтобы вам было комфортно при посещении МКНЦ.

    Staff

    Filonenko Darya Aleksandrovna

    Filonenko Darya Aleksandrovna

    Oncologist

    Head of department

    Oncology Day Hospital Department

    GBUZ Moscow Clinical Scientific Center named after Loginov MHD